Salicylate promotes myeloperoxidase-initiated LDL oxidation: Antagonization by its metabolite gentisic acid

Free Radical Biology and Medicine

Volumn 26, Issue 9-10, 1999, Pages 1253-1260

  Hermann, Marcela ^a   Kapiotis, Stylianos ^b   Hofbauer, Roland ^b   Seelos, Christian ^a   Held, Irmtraud ^a   Gmeiner, Bernhard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acetyl salicylic acid; Aspirin; Atherosclerosis; Free radicals; Gentisic acid; Lipid peroxidation; Myeloperoxidase; Oxidized LDL; Salicylate

Indexed keywords

ASCORBIC ACID; AZIDE; CATALASE; CYANIDE; GENTISIC ACID; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; SALICYLIC ACID;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID OXIDATION; LIPID PEROXIDATION; NEUTROPHIL; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; ASPIRIN; FREE RADICAL SCAVENGERS; FREE RADICALS; GENTISATES; HUMANS; HYDROXYBENZOIC ACIDS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; NEUTROPHILS; OXIDANTS; OXIDATION-REDUCTION; PEROXIDASE; PHENOLS; SALICYLIC ACID; TYROSINE;

EID: 0033015418     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00322-0     Document Type: Article

References (50)

1. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
3. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
4. Malterud K.E., Farbrot T.L., Huse A.E., Sund R.B. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology. 47:1993;77-85.
5. Clifton P.M. Antioxidant vitamins and coronary heart disease risk. Curr. Opin. Lipidol. 6:1995;20-24.
6. Buettner G.R. The pecking order of free radicals and antioxidants lipid peroxidation, α-tocopherol, and ascorbate . Arch. Biochem. Biophys. 300:1993;535-543.
7. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269:1994;16712-16719.
8. Pentikainen M.O., Lindstedt K.A., Kovanen P.T. Inhibition of the oxidative modification of LDL by nitecapone. Arterioscler. Thromb. Vasc. Biol. 15:1995;740-747.
9. Nenseter M.S., Halvorsen B., Rosvold O., Rustan A.C., Drevon C.A. Paracetamol inhibits copper ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL. Arterioscler. Thromb. Vasc. Biol. 15:1995;1338-1344.
10. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
11. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165-172.
12. Darley Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 17:1992;9-20.
13. Chang G.J., Woo P., Honda H.M., Ignarro L.J., Young L., Berliner J.A., Demer L.L. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. Arterioscler. Thromb. 14:1994;1808-1814.
14. Wieland E., Parthasarathy S., Steinberg D. Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro a model for in vivo oxidation? Proc. Natl. Acad. Sci. USA. 90:1993;5929-5933.
15. Bowry V.W., Ingold K.U., Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem. J. 288:1992;341-344.
16. Witting P.K., Upston J.M., Stocker R. Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horseradish peroxidase. Biochemistry. 36:1997;1251-1258.
17. Singh R.J., Feix J.B., Mchaourab H.S., Hogg N., Kalyanaraman B. Spin-labeling study of the oxidative damage to low-density lipoprotein. Arch. Biochem. Biophys. 320:1995;155-161.
18. Santanam N., Parthasarathy S. Paradoxical actions of antioxidants in the oxidation of low density lipoprotein by peroxidases. J. Clin. Invest. 95:1995;2594-2600.
19. Heinecke J.W., Li W., Daehnke H.L. III, Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268:1993;4069-4077.
20. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:1994;20394-20400.
21. Stocker R. Lipoprotein oxidation; mechanistic aspects, methodological approaches and clinical relevance. Curr. Opin. Lipidol. 5:1994;422-433.
22. -/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis . J. Lipid Res. 39:1998;354-368.
23. Neuzil J., Thomas S.R., Stocker R. Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation. Free Radic. Biol. Med. 22:1997;51-71.
24. Gross A.J., Sizer I.W. The oxidation of tyramine, tyrosine, and related compounds by peroxidase. J. Biol. Chem. 234:1959;1611-1614.
25. Bayse G.S., Michaels A.W., Morrison M. The peroxidase-catalyzed oxidation of tyrosine. Biochim. Biophys. Acta. 284:1972;34-42.
26. Valoti M., Sipe H.J. Jr, Sgaragli G., Mason R.P. Free radical intermediates during peroxidase oxidation of 2-t-butyl-4-methoxyphenol, 2,6-di-t-butyl-4-methylphenol, and related phenol compounds. Arch. Biochem. Biophys. 269:1989;423-432.
27. Kapiotis S., Sengoelge G., Hermann M., Held I., Seelos C., Gmeiner B.M.K. Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL. Arterioscler. Thromb. Vasc. Biol. 17:1997;2855-2860.
28. Fuster V., Dyken M.L., Vokonas P.S., Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. Circulation. 87:1993;659-675.
29. Ranke C., Hecker H., Creutzig A., Alexander K. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation. 87:1993;1873-1879.
30. Shiga T., Imaizumi K. Generation of phenoxy radicals by methemoglobin-hydrogen peroxide studies by electron paramagnetic resonance. Arch. Biochem. Biophys. 154:1973;540-547.
31. Shiga T., Imaizumi K. Electron spin resonance study on peroxidase- and oxidase-reactions of horse radish peroxidase and methemoglobin. Arch. Biochem. Biophys. 167:1975;469-479.
32. Hermann M., Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler. Thromb. 12:1992;1503-1506.
33. Pertoft H., Laurent T.C. Isopycnic separation of cells and cell organelles by centrifugation in modified colloidal silica gradients. Catsimpoolas N. Methods of cell separation. Vol. 1:1977;25-65 Plenum Press, New York.
34. Watt S.M., Burgess A.W., Metcalf D. Isolation and surface labeling of murine polymorphonuclear neutrophils. J. Cell Physiol. 100:1979;1-21.
35. Metcalf, J. A.; Gallin, J.; Nauseef, W. M.; Root, R. K., eds. Laboratory manual of neutrophil function. New York: Raven Press; 1986.
36. Scaccini C., Jialal I. LDL modification by activated polymorphonuclear leukocytes a cellular model of mild oxidative stress . Free. Radic. Biol. Med. 16:1994;49-55.
37. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
38. Dole V.P., Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235:1960;2595-2599.
39. El Saadani M., Esterbauer H., el Sayed M., Goher M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630.
40. Gebicki J.M., Collins J., Baoutina A., Phair P. The limitations of an iodometric aerobic assay for peroxides. Anal Biochem. 240:1996;235-241.
41. Wallin B., Camejo G. Lipoprotein oxidation and measurement of hydroperoxide formation in a single microtitre plate. Scand. J. Clin. Lab. Invest. 54:1994;341-346.
42. Mihaljevic B., Katusin-Razem B., Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free. Radic. Biol. Med. 21:1996;53-63.
43. Trinder P. Rapid determination of salicylate in biological fluids. Biochem. J. 57:1953;301-303.
44. Gmeiner B., Seelos C. Phosphorylation of tyrosine prevents dityrosine formation in vitro. FEBS Lett. 255:1989;395-397.
45. Gmeiner B.M., Seelos C.C. Tyrosine phosphorylation blocks tyrosine free radical formation and, hence, the hormonogenic iodination reaction. Free Radic. Biol. Med. 21:1996;349-351.
46. Forth, W.; Henschler, D.; Rummel, W., eds. Allgemeine und spezielle Pharmakologie und Toxikologie. Mannheim, Wien, Zürich: Wissenschaftsverlag; 1987.
47. Maziere C., Goldstein S., Moreau M., Maziere J.C., Polonovski J. Aspirin induces alterations in low-density lipoprotein and decreases its catabolism by cultured human fibroblasts. FEBS Lett. 218:1987;243-246.
48. Giulivi C., Davies K.J.A. Dityrosine a marker for oxidatively modified proteins and selective proteolysis . Methods Enzymol. 233:1994;363-371.
49. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437-444.
50. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.